Market Overview

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD)

42.51 -0.73 (-1.69%)

Analyst Ratings

DateResearch FirmActionCurrentPT
10/01/19RBC CapitalInitiates Coverage OnOutperform60.0
9/23/19Cantor FitzgeraldMaintainsOverweight56.0
9/13/19SVB LeerinkUpgradesOutperform50.0
9/10/19Canaccord GenuityUpgradesBuy
9/09/19NeedhamMaintainsBuy60.0
9/03/19Stifel NicolausMaintainsHold28.0
8/27/19Cantor FitzgeraldReiteratesOverweight40.0
5/31/19Raymond JamesReiteratesStrong Buy43.0
12/10/18Canaccord GenuityInitiates Coverage OnHold23.0
11/16/18UBSInitiates Coverage OnNeutral39.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter